ArticleCancers2020

CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-b Signaling.

Bo-Reum Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.